Clin2
NCT07273643Possibly a fitRecruiting

Studying tiny particles in cord blood of very premature babies

Intraventricular HemorrhagePulmonary HemorrhageDeathELGAN (22-28SA)Bronchopulmonary Dysplasia (BPD)ShockExtracellular VesiclesEnterocolitis, Necrotizing

Part of Digestive system, Genetic & congenital, Lungs & breathing clinical trials.

This study looks at microscopic particles called extracellular vesicles in the umbilical cord blood of babies born before 28 weeks. Researchers want to see if these particles can help predict severe health problems or death, and eventually improve care for extremely premature newborns.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
birth to 3 months
Study type
Observational

Who can take part

  • Mother is 18 or older and speaks or understands French
  • Baby is born before 28 weeks of pregnancy at Montpellier University Hospital
  • Cord blood is collected right after birth
  • Parents agree (do not say no) to the study before the sample is taken
  • Baby is alive at birth

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06737965Not yet recruiting
Heart and blood vessel development in very early babies

This study looks at how the heart and blood vessels develop in babies born very early (before 28 weeks), compared with babies who are more mature. It aims to help find ways to better protect the hearts of premature babies in the future.

Montpellier
NCT07502781Not yet recruiting
Cord blood cells for transfusion in extremely premature babies

This study tests whether red blood cells made from donated cord blood are safe and effective for very premature babies who need a transfusion. It may offer an alternative to standard donor blood for these fragile infants.

Barcelona
NCT07058025Not yet recruiting· Phase 2
Stem cell therapy to prevent lung damage in premature babies

This trial tests whether giving stem cells to very premature babies can help prevent bronchopulmonary dysplasia, a lung condition that often affects babies born before 28 weeks. The stem cells are given through an IV, and the study compares them to a placebo to see if they improve lung health.

Edmonton, Alberta
NCT02881970Recruiting· Phase 1/Phase 2
Cord blood stem cell treatment for newborn brain injury

This early-phase study tests whether using a baby’s own cord blood stem cells is safe and feasible for newborns with brain injury from lack of oxygen around birth. It may help researchers find new ways to treat hypoxic-ischemic encephalopathy (brain injury due to oxygen deprivation) in addition to standard care like cooling.

Marseille
NCT07169110Not yet recruiting
Babies born early: reliable exams by different caregivers

This study tests whether different caregivers get the same results when they observe very premature babies using a special scale. It may help improve how we measure development in early-born infants.

Toulouse
NCT06812507Recruiting
Umbilical cord blood transfer in very premature babies

This trial tests different ways of transferring blood from the umbilical cord to very premature babies (born at or before 32 weeks) to see if it can prevent complications of prematurity and improve their blood counts. It aims to find the best method for helping these vulnerable newborns.

Alexandria

Hear when a new Intraventricular Hemorrhage trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.